Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pain | 81 | 2022 | 5098 | 7.720 |
Why?
|
Migraine Disorders | 48 | 2023 | 1710 | 7.460 |
Why?
|
Analgesia | 15 | 2023 | 461 | 4.630 |
Why?
|
Brain | 94 | 2024 | 27158 | 4.200 |
Why?
|
Complex Regional Pain Syndromes | 11 | 2020 | 122 | 3.600 |
Why?
|
Nerve Net | 24 | 2020 | 2307 | 3.200 |
Why?
|
Somatosensory Cortex | 14 | 2019 | 506 | 3.050 |
Why?
|
Neuralgia | 15 | 2022 | 618 | 3.010 |
Why?
|
Pain Measurement | 44 | 2024 | 3576 | 2.940 |
Why?
|
Brain Mapping | 54 | 2022 | 6597 | 2.840 |
Why?
|
Magnetic Resonance Imaging | 101 | 2022 | 36570 | 2.380 |
Why?
|
Reward | 11 | 2019 | 980 | 2.230 |
Why?
|
Hot Temperature | 28 | 2017 | 1441 | 2.210 |
Why?
|
Analgesics | 17 | 2021 | 1068 | 2.190 |
Why?
|
Neural Pathways | 26 | 2021 | 3079 | 2.140 |
Why?
|
Hyperalgesia | 10 | 2023 | 527 | 1.870 |
Why?
|
Pain Threshold | 12 | 2021 | 606 | 1.590 |
Why?
|
Trigeminal Nerve | 10 | 2014 | 248 | 1.570 |
Why?
|
Pain Perception | 4 | 2020 | 197 | 1.410 |
Why?
|
Nociceptors | 8 | 2015 | 460 | 1.380 |
Why?
|
Pain, Intractable | 3 | 2023 | 132 | 1.320 |
Why?
|
Post-Traumatic Headache | 3 | 2021 | 69 | 1.240 |
Why?
|
Enkephalins | 12 | 1999 | 139 | 1.220 |
Why?
|
Eye Pain | 5 | 2021 | 46 | 1.210 |
Why?
|
Cerebral Cortex | 19 | 2017 | 5753 | 1.200 |
Why?
|
Habenula | 3 | 2013 | 40 | 1.200 |
Why?
|
Basal Ganglia | 5 | 2015 | 549 | 1.170 |
Why?
|
Sumatriptan | 2 | 2019 | 66 | 1.150 |
Why?
|
Reflex Sympathetic Dystrophy | 2 | 2019 | 60 | 1.100 |
Why?
|
Brain Stem | 9 | 2022 | 858 | 1.070 |
Why?
|
Physical Stimulation | 17 | 2017 | 514 | 1.020 |
Why?
|
Photophobia | 7 | 2019 | 77 | 1.020 |
Why?
|
Irritable Bowel Syndrome | 4 | 2019 | 454 | 1.020 |
Why?
|
Central Nervous System | 7 | 2010 | 1345 | 0.990 |
Why?
|
Spectroscopy, Near-Infrared | 7 | 2021 | 749 | 0.970 |
Why?
|
Amygdala | 8 | 2022 | 1375 | 0.960 |
Why?
|
Hypothalamus | 13 | 2017 | 1003 | 0.940 |
Why?
|
Spinal Cord | 6 | 2020 | 1811 | 0.930 |
Why?
|
Stress, Psychological | 10 | 2024 | 4526 | 0.920 |
Why?
|
Protein Precursors | 12 | 1999 | 1134 | 0.920 |
Why?
|
Humans | 234 | 2024 | 766812 | 0.910 |
Why?
|
Phantom Limb | 2 | 2023 | 106 | 0.900 |
Why?
|
Stress, Physiological | 8 | 2024 | 1407 | 0.880 |
Why?
|
Purine Nucleosides | 4 | 2004 | 30 | 0.840 |
Why?
|
Gyrus Cinguli | 5 | 2021 | 1118 | 0.830 |
Why?
|
Behavior, Addictive | 4 | 2016 | 429 | 0.810 |
Why?
|
Cornea | 7 | 2021 | 1316 | 0.810 |
Why?
|
Cerebellum | 7 | 2019 | 1520 | 0.800 |
Why?
|
Solitary Nucleus | 1 | 2022 | 54 | 0.790 |
Why?
|
Efferent Pathways | 3 | 2020 | 164 | 0.790 |
Why?
|
Placebo Effect | 2 | 2017 | 515 | 0.780 |
Why?
|
Diffusion Tensor Imaging | 5 | 2024 | 2419 | 0.770 |
Why?
|
Thalamus | 9 | 2021 | 1040 | 0.760 |
Why?
|
Dry Eye Syndromes | 3 | 2021 | 385 | 0.760 |
Why?
|
Awareness | 2 | 2018 | 653 | 0.750 |
Why?
|
Wakefulness | 4 | 2021 | 1282 | 0.750 |
Why?
|
Allostasis | 2 | 2012 | 76 | 0.750 |
Why?
|
Nucleus Accumbens | 4 | 2014 | 360 | 0.750 |
Why?
|
Oxyhemoglobins | 1 | 2022 | 213 | 0.740 |
Why?
|
Buprenorphine | 5 | 2013 | 667 | 0.730 |
Why?
|
Trigeminal Ganglion | 4 | 2009 | 186 | 0.730 |
Why?
|
Analgesics, Opioid | 13 | 2022 | 3837 | 0.720 |
Why?
|
Central Nervous System Diseases | 4 | 2014 | 518 | 0.720 |
Why?
|
Image Processing, Computer-Assisted | 25 | 2021 | 8928 | 0.720 |
Why?
|
Placebos | 6 | 2017 | 1659 | 0.710 |
Why?
|
Autonomic Nervous System | 3 | 2022 | 707 | 0.700 |
Why?
|
Rats, Sprague-Dawley | 25 | 2020 | 8108 | 0.700 |
Why?
|
Opioid-Related Disorders | 6 | 2022 | 2188 | 0.680 |
Why?
|
Male | 128 | 2024 | 364154 | 0.680 |
Why?
|
Receptors, Opioid | 2 | 2017 | 145 | 0.680 |
Why?
|
Corneal Diseases | 4 | 2016 | 535 | 0.670 |
Why?
|
Central Nervous System Agents | 2 | 2013 | 71 | 0.670 |
Why?
|
Diagnostic Imaging | 7 | 2014 | 3530 | 0.670 |
Why?
|
Anesthesia, General | 3 | 2022 | 1188 | 0.660 |
Why?
|
Trigeminal Neuralgia | 3 | 2010 | 103 | 0.650 |
Why?
|
Catastrophization | 6 | 2024 | 352 | 0.650 |
Why?
|
Naproxen | 1 | 2019 | 101 | 0.640 |
Why?
|
Peripheral Nerves | 2 | 2021 | 490 | 0.630 |
Why?
|
Models, Neurological | 6 | 2019 | 1747 | 0.630 |
Why?
|
Neuronal Plasticity | 8 | 2018 | 1446 | 0.630 |
Why?
|
Ophthalmic Nerve | 2 | 2016 | 42 | 0.620 |
Why?
|
Stress Disorders, Post-Traumatic | 4 | 2022 | 4628 | 0.610 |
Why?
|
Gambling | 2 | 2012 | 192 | 0.610 |
Why?
|
Sex Characteristics | 6 | 2019 | 2645 | 0.600 |
Why?
|
Neurobiology | 2 | 2018 | 135 | 0.590 |
Why?
|
Thermosensing | 3 | 2020 | 56 | 0.590 |
Why?
|
Emotions | 9 | 2021 | 2758 | 0.590 |
Why?
|
Animals | 78 | 2023 | 168939 | 0.590 |
Why?
|
Hallucinogens | 1 | 2021 | 212 | 0.590 |
Why?
|
Rest | 7 | 2019 | 940 | 0.580 |
Why?
|
Brain Concussion | 4 | 2021 | 1431 | 0.570 |
Why?
|
Cerebrum | 1 | 2018 | 132 | 0.570 |
Why?
|
Pelvic Pain | 1 | 2019 | 300 | 0.560 |
Why?
|
Drug Design | 3 | 2011 | 1043 | 0.560 |
Why?
|
Prefrontal Cortex | 5 | 2019 | 2224 | 0.560 |
Why?
|
Trigeminal Nerve Diseases | 2 | 2008 | 48 | 0.550 |
Why?
|
Cold Temperature | 8 | 2013 | 793 | 0.550 |
Why?
|
Avoidance Learning | 1 | 2018 | 248 | 0.550 |
Why?
|
Ketamine | 2 | 2015 | 527 | 0.540 |
Why?
|
Pulvinar | 2 | 2019 | 24 | 0.530 |
Why?
|
Adult | 74 | 2024 | 223305 | 0.530 |
Why?
|
Drug Discovery | 3 | 2014 | 1065 | 0.520 |
Why?
|
Consciousness | 3 | 2018 | 602 | 0.520 |
Why?
|
Paraventricular Hypothalamic Nucleus | 6 | 1999 | 121 | 0.520 |
Why?
|
Blood-Brain Barrier | 5 | 2020 | 1028 | 0.510 |
Why?
|
Unconsciousness | 1 | 2018 | 252 | 0.510 |
Why?
|
Touch | 6 | 2010 | 313 | 0.510 |
Why?
|
Serotonin 5-HT1 Receptor Agonists | 1 | 2015 | 42 | 0.510 |
Why?
|
Touch Perception | 1 | 2017 | 106 | 0.500 |
Why?
|
Cortical Spreading Depression | 2 | 2018 | 288 | 0.500 |
Why?
|
Female | 87 | 2024 | 396532 | 0.500 |
Why?
|
Endometriosis | 2 | 2022 | 868 | 0.490 |
Why?
|
Glutamine | 2 | 2016 | 575 | 0.480 |
Why?
|
Narcotics | 3 | 2006 | 332 | 0.480 |
Why?
|
Clinical Trials as Topic | 8 | 2016 | 8045 | 0.480 |
Why?
|
Peripheral Nervous System Diseases | 5 | 2019 | 713 | 0.480 |
Why?
|
Adolescent | 37 | 2024 | 88902 | 0.480 |
Why?
|
Light | 7 | 2022 | 1358 | 0.470 |
Why?
|
Neuropharmacology | 2 | 2011 | 19 | 0.470 |
Why?
|
Afferent Pathways | 4 | 2012 | 303 | 0.470 |
Why?
|
Anatomy, Artistic | 1 | 2014 | 50 | 0.460 |
Why?
|
Drug Resistance | 2 | 2018 | 1592 | 0.460 |
Why?
|
Hemodynamics | 4 | 2021 | 4188 | 0.460 |
Why?
|
Pain, Postoperative | 3 | 2019 | 1768 | 0.450 |
Why?
|
Rats | 26 | 2020 | 23717 | 0.450 |
Why?
|
Cerebrovascular Circulation | 4 | 2019 | 2671 | 0.450 |
Why?
|
Tibial Nerve | 2 | 2005 | 55 | 0.450 |
Why?
|
Aspartic Acid | 1 | 2016 | 575 | 0.440 |
Why?
|
Anesthetics | 2 | 2017 | 525 | 0.430 |
Why?
|
Young Adult | 29 | 2024 | 59939 | 0.430 |
Why?
|
Organ Specificity | 3 | 2019 | 1968 | 0.430 |
Why?
|
Nalbuphine | 1 | 2013 | 20 | 0.430 |
Why?
|
Demyelinating Diseases | 1 | 2015 | 354 | 0.420 |
Why?
|
Headache | 4 | 2023 | 1260 | 0.410 |
Why?
|
Sciatic Neuropathy | 2 | 2005 | 76 | 0.410 |
Why?
|
Frontal Lobe | 3 | 2016 | 1408 | 0.410 |
Why?
|
Psychophysics | 6 | 2019 | 292 | 0.400 |
Why?
|
Hypesthesia | 2 | 2019 | 106 | 0.400 |
Why?
|
Drug Evaluation, Preclinical | 5 | 2014 | 1331 | 0.400 |
Why?
|
Erythromelalgia | 1 | 2012 | 15 | 0.400 |
Why?
|
Visual Pathways | 3 | 2019 | 554 | 0.400 |
Why?
|
Yohimbine | 1 | 2012 | 63 | 0.400 |
Why?
|
Adaptation, Psychological | 2 | 2014 | 2662 | 0.390 |
Why?
|
Pleasure | 1 | 2012 | 41 | 0.390 |
Why?
|
Neurotransmitter Agents | 5 | 2019 | 661 | 0.390 |
Why?
|
Cerebellar Diseases | 1 | 2014 | 227 | 0.390 |
Why?
|
gamma-Aminobutyric Acid | 7 | 2019 | 1139 | 0.390 |
Why?
|
Oxygen | 12 | 2015 | 4252 | 0.390 |
Why?
|
Locus Coeruleus | 1 | 2014 | 241 | 0.390 |
Why?
|
Tomography, Optical | 2 | 2009 | 129 | 0.380 |
Why?
|
Pons | 2 | 2012 | 239 | 0.380 |
Why?
|
Attitude | 1 | 2016 | 768 | 0.380 |
Why?
|
Blepharospasm | 1 | 2011 | 34 | 0.370 |
Why?
|
Parent-Child Relations | 1 | 2016 | 772 | 0.370 |
Why?
|
Periaqueductal Gray | 1 | 2011 | 111 | 0.370 |
Why?
|
Child | 27 | 2024 | 80670 | 0.370 |
Why?
|
Disease Models, Animal | 10 | 2019 | 18329 | 0.370 |
Why?
|
Antibiotics, Antineoplastic | 2 | 2008 | 678 | 0.360 |
Why?
|
Motor Activity | 1 | 2020 | 2711 | 0.350 |
Why?
|
Basal Metabolism | 1 | 2011 | 163 | 0.350 |
Why?
|
Adaptation, Physiological | 3 | 2012 | 1312 | 0.350 |
Why?
|
Membrane Potentials | 1 | 2013 | 1085 | 0.350 |
Why?
|
Glutamic Acid | 1 | 2016 | 1181 | 0.350 |
Why?
|
Guidelines as Topic | 3 | 2011 | 1394 | 0.340 |
Why?
|
Trigeminal Caudal Nucleus | 1 | 2009 | 18 | 0.330 |
Why?
|
Excitatory Amino Acid Agents | 1 | 2009 | 26 | 0.330 |
Why?
|
Gene Expression Regulation | 13 | 1999 | 11924 | 0.330 |
Why?
|
Motor Cortex | 4 | 2014 | 1005 | 0.330 |
Why?
|
Pain Insensitivity, Congenital | 1 | 2009 | 8 | 0.320 |
Why?
|
Affect | 3 | 2013 | 1494 | 0.320 |
Why?
|
Anesthetics, Dissociative | 1 | 2009 | 81 | 0.310 |
Why?
|
Medical Records | 1 | 2014 | 1408 | 0.310 |
Why?
|
Middle Aged | 41 | 2024 | 223267 | 0.310 |
Why?
|
beta-Galactosidase | 8 | 1999 | 573 | 0.310 |
Why?
|
Comorbidity | 2 | 2022 | 10580 | 0.300 |
Why?
|
Mononeuropathies | 1 | 2008 | 13 | 0.300 |
Why?
|
Triazines | 1 | 2010 | 311 | 0.300 |
Why?
|
Naloxone | 3 | 2013 | 372 | 0.300 |
Why?
|
Case-Control Studies | 12 | 2019 | 22248 | 0.300 |
Why?
|
Neurosciences | 1 | 2013 | 384 | 0.300 |
Why?
|
Colonoscopy | 1 | 2016 | 1409 | 0.290 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 4 | 1999 | 501 | 0.290 |
Why?
|
Mental Disorders | 3 | 2017 | 6869 | 0.290 |
Why?
|
Optic Nerve | 1 | 2011 | 568 | 0.280 |
Why?
|
Interleukin-1 | 3 | 2000 | 1251 | 0.280 |
Why?
|
Comprehension | 1 | 2012 | 638 | 0.280 |
Why?
|
Aging | 2 | 2017 | 8728 | 0.280 |
Why?
|
Tics | 1 | 2007 | 76 | 0.280 |
Why?
|
Drug Evaluation | 1 | 2008 | 642 | 0.270 |
Why?
|
Cluster Headache | 1 | 2007 | 54 | 0.270 |
Why?
|
Trigeminal Nuclei | 1 | 2006 | 39 | 0.270 |
Why?
|
Parents | 3 | 2018 | 3592 | 0.270 |
Why?
|
Cross-Over Studies | 5 | 2013 | 2105 | 0.260 |
Why?
|
Behavior | 3 | 2017 | 538 | 0.260 |
Why?
|
Neurons, Afferent | 3 | 2010 | 498 | 0.260 |
Why?
|
Temporal Lobe | 4 | 2019 | 1716 | 0.260 |
Why?
|
Brachial Plexus | 1 | 2008 | 171 | 0.260 |
Why?
|
Social Behavior | 1 | 2012 | 1147 | 0.260 |
Why?
|
Face | 3 | 2009 | 1029 | 0.260 |
Why?
|
Capsaicin | 1 | 2007 | 233 | 0.260 |
Why?
|
Reaction Time | 3 | 2012 | 2085 | 0.250 |
Why?
|
Neurons | 10 | 2017 | 9515 | 0.250 |
Why?
|
Brain Chemistry | 1 | 2009 | 951 | 0.250 |
Why?
|
Putamen | 2 | 2020 | 288 | 0.250 |
Why?
|
Motivation | 2 | 2016 | 2020 | 0.240 |
Why?
|
Chronic Disease | 10 | 2021 | 9358 | 0.240 |
Why?
|
Capillary Permeability | 2 | 2019 | 772 | 0.240 |
Why?
|
Societies, Medical | 1 | 2017 | 3957 | 0.240 |
Why?
|
Injections, Intravenous | 4 | 2017 | 1377 | 0.240 |
Why?
|
Nerve Fibers | 2 | 2021 | 706 | 0.240 |
Why?
|
Nervous System Diseases | 2 | 2022 | 1659 | 0.240 |
Why?
|
Pediatrics | 2 | 2023 | 3614 | 0.230 |
Why?
|
Diffusion Magnetic Resonance Imaging | 4 | 2024 | 2809 | 0.230 |
Why?
|
Tongue | 1 | 2007 | 406 | 0.230 |
Why?
|
Empathy | 1 | 2009 | 474 | 0.230 |
Why?
|
Anxiety | 5 | 2024 | 4668 | 0.230 |
Why?
|
Morphine | 3 | 2006 | 658 | 0.230 |
Why?
|
Substance-Related Disorders | 3 | 2016 | 4421 | 0.220 |
Why?
|
Cyclohexanecarboxylic Acids | 4 | 2014 | 139 | 0.220 |
Why?
|
Receptors, Opioid, mu | 2 | 2017 | 167 | 0.220 |
Why?
|
Movement | 2 | 2007 | 1468 | 0.220 |
Why?
|
Spin Labels | 2 | 2017 | 334 | 0.220 |
Why?
|
Medulla Oblongata | 3 | 2022 | 247 | 0.220 |
Why?
|
Dopamine | 3 | 2023 | 1581 | 0.220 |
Why?
|
Lipopolysaccharides | 3 | 2000 | 2215 | 0.210 |
Why?
|
Amines | 4 | 2014 | 280 | 0.210 |
Why?
|
Cognition Disorders | 1 | 2017 | 3967 | 0.210 |
Why?
|
Endocannabinoids | 1 | 2023 | 113 | 0.210 |
Why?
|
Naltrexone | 3 | 2013 | 319 | 0.210 |
Why?
|
Dura Mater | 2 | 2018 | 292 | 0.200 |
Why?
|
Polyneuropathies | 1 | 2004 | 139 | 0.200 |
Why?
|
Hand | 2 | 2008 | 910 | 0.200 |
Why?
|
Peroneal Nerve | 1 | 2002 | 80 | 0.200 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2009 | 1514 | 0.200 |
Why?
|
Technology, Pharmaceutical | 1 | 2002 | 83 | 0.200 |
Why?
|
Internet | 1 | 2014 | 3113 | 0.200 |
Why?
|
Drug Delivery Systems | 3 | 2020 | 2210 | 0.200 |
Why?
|
Neurites | 1 | 2024 | 389 | 0.200 |
Why?
|
Pharmaceutical Preparations | 1 | 2010 | 1086 | 0.190 |
Why?
|
Neuroprotective Agents | 1 | 2008 | 956 | 0.190 |
Why?
|
Analysis of Variance | 5 | 2016 | 6214 | 0.190 |
Why?
|
Infusions, Intravenous | 3 | 2013 | 2228 | 0.190 |
Why?
|
Evoked Potentials, Somatosensory | 2 | 2015 | 240 | 0.190 |
Why?
|
Doxorubicin | 1 | 2008 | 2229 | 0.180 |
Why?
|
Cohort Studies | 9 | 2023 | 41706 | 0.180 |
Why?
|
Sodium Chloride | 2 | 2017 | 580 | 0.180 |
Why?
|
Ganglia, Spinal | 1 | 2023 | 529 | 0.180 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2013 | 10745 | 0.180 |
Why?
|
Nerve Fibers, Myelinated | 2 | 2019 | 951 | 0.180 |
Why?
|
Pituitary-Adrenal System | 1 | 2024 | 553 | 0.170 |
Why?
|
Anticonvulsants | 1 | 2010 | 1921 | 0.170 |
Why?
|
Drug Monitoring | 2 | 2010 | 962 | 0.170 |
Why?
|
Infusions, Intraventricular | 1 | 2019 | 31 | 0.170 |
Why?
|
Pilot Projects | 5 | 2024 | 8728 | 0.170 |
Why?
|
Sleep Disorders, Circadian Rhythm | 1 | 2022 | 197 | 0.170 |
Why?
|
Foot | 1 | 2004 | 576 | 0.170 |
Why?
|
Headache Disorders | 1 | 2022 | 152 | 0.170 |
Why?
|
Motor Skills Disorders | 1 | 2020 | 89 | 0.160 |
Why?
|
Arrhythmias, Cardiac | 2 | 2022 | 2257 | 0.160 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2024 | 702 | 0.160 |
Why?
|
Hippocampus | 1 | 2012 | 3776 | 0.160 |
Why?
|
Temperature | 2 | 2021 | 2231 | 0.160 |
Why?
|
Age Factors | 4 | 2019 | 18397 | 0.160 |
Why?
|
Low Back Pain | 1 | 2008 | 986 | 0.160 |
Why?
|
Anesthesia | 1 | 2010 | 1595 | 0.160 |
Why?
|
Sensory Thresholds | 2 | 2019 | 377 | 0.160 |
Why?
|
Brain Diseases | 1 | 2008 | 1552 | 0.160 |
Why?
|
Sprains and Strains | 1 | 2019 | 76 | 0.160 |
Why?
|
Microbubbles | 1 | 2020 | 137 | 0.160 |
Why?
|
Illness Behavior | 1 | 2018 | 23 | 0.160 |
Why?
|
Double-Blind Method | 6 | 2023 | 12430 | 0.160 |
Why?
|
Benzodiazepines | 4 | 2013 | 1137 | 0.160 |
Why?
|
Habituation, Psychophysiologic | 1 | 1999 | 144 | 0.150 |
Why?
|
Buttocks | 1 | 1998 | 111 | 0.150 |
Why?
|
Psychiatry | 1 | 2011 | 1715 | 0.150 |
Why?
|
Synaptic Transmission | 3 | 2017 | 1175 | 0.150 |
Why?
|
Discrimination Learning | 1 | 2020 | 276 | 0.150 |
Why?
|
Quality Control | 2 | 2011 | 834 | 0.150 |
Why?
|
Drug Utilization Review | 1 | 1999 | 248 | 0.150 |
Why?
|
Dark Adaptation | 1 | 2019 | 224 | 0.150 |
Why?
|
Electroretinography | 2 | 2019 | 524 | 0.150 |
Why?
|
Pia Mater | 1 | 2018 | 85 | 0.150 |
Why?
|
Narcotic Antagonists | 4 | 2012 | 591 | 0.150 |
Why?
|
Thalamic Nuclei | 2 | 2023 | 110 | 0.150 |
Why?
|
Nitroglycerin | 1 | 2019 | 332 | 0.150 |
Why?
|
Color Perception | 1 | 2018 | 211 | 0.140 |
Why?
|
Parkinson Disease | 1 | 2011 | 2884 | 0.140 |
Why?
|
Evoked Potentials, Visual | 2 | 2019 | 417 | 0.140 |
Why?
|
Recombinant Fusion Proteins | 4 | 1998 | 3738 | 0.140 |
Why?
|
Mice, Transgenic | 10 | 2018 | 9546 | 0.140 |
Why?
|
Melatonin | 1 | 2022 | 670 | 0.140 |
Why?
|
Post-Concussion Syndrome | 1 | 2019 | 257 | 0.130 |
Why?
|
Triamcinolone | 1 | 1996 | 68 | 0.130 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2020 | 792 | 0.130 |
Why?
|
Trigeminal Nucleus, Spinal | 2 | 2008 | 21 | 0.130 |
Why?
|
Basal Ganglia Diseases | 1 | 2016 | 145 | 0.130 |
Why?
|
Treatment Outcome | 11 | 2023 | 65286 | 0.130 |
Why?
|
Calcitonin Gene-Related Peptide | 2 | 2016 | 327 | 0.130 |
Why?
|
Biomedical Research | 2 | 2013 | 3459 | 0.130 |
Why?
|
Positron-Emission Tomography | 4 | 2017 | 6548 | 0.130 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2008 | 3360 | 0.130 |
Why?
|
Drug-Seeking Behavior | 1 | 2016 | 45 | 0.130 |
Why?
|
Facial Pain | 1 | 2016 | 119 | 0.120 |
Why?
|
Depression | 4 | 2021 | 8225 | 0.120 |
Why?
|
Parietal Lobe | 3 | 2014 | 860 | 0.120 |
Why?
|
Ankle Injuries | 1 | 2019 | 339 | 0.120 |
Why?
|
Retinal Cone Photoreceptor Cells | 1 | 2016 | 183 | 0.120 |
Why?
|
Hypoglycemia | 1 | 2022 | 896 | 0.120 |
Why?
|
Corticotropin-Releasing Hormone | 1 | 2016 | 362 | 0.120 |
Why?
|
Drug Industry | 2 | 2011 | 791 | 0.120 |
Why?
|
Muscle, Skeletal | 2 | 2020 | 4968 | 0.120 |
Why?
|
Vasodilator Agents | 1 | 2019 | 988 | 0.120 |
Why?
|
Drug Combinations | 2 | 2019 | 2085 | 0.120 |
Why?
|
Midazolam | 1 | 2016 | 267 | 0.110 |
Why?
|
Fluoroscopy | 1 | 1998 | 948 | 0.110 |
Why?
|
Neuropeptides | 2 | 2017 | 950 | 0.110 |
Why?
|
Biological Clocks | 1 | 2016 | 320 | 0.110 |
Why?
|
Neurosecretory Systems | 1 | 1995 | 223 | 0.110 |
Why?
|
Cross-Sectional Studies | 8 | 2023 | 26309 | 0.110 |
Why?
|
Lidocaine | 1 | 1997 | 545 | 0.110 |
Why?
|
Genes, fos | 1 | 1994 | 176 | 0.110 |
Why?
|
Pruritus | 1 | 1997 | 378 | 0.110 |
Why?
|
Parahippocampal Gyrus | 1 | 2014 | 117 | 0.110 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 1997 | 663 | 0.110 |
Why?
|
Electromyography | 1 | 1998 | 1398 | 0.110 |
Why?
|
Reproducibility of Results | 9 | 2015 | 20146 | 0.110 |
Why?
|
Tears | 1 | 2015 | 254 | 0.110 |
Why?
|
Interviews as Topic | 1 | 2021 | 2741 | 0.110 |
Why?
|
Photic Stimulation | 3 | 2019 | 1989 | 0.100 |
Why?
|
Physicians | 2 | 2023 | 4591 | 0.100 |
Why?
|
Genitalia, Male | 1 | 1992 | 87 | 0.100 |
Why?
|
Conflict of Interest | 1 | 2017 | 556 | 0.100 |
Why?
|
Disease Susceptibility | 1 | 2019 | 1791 | 0.100 |
Why?
|
Neurologic Examination | 1 | 2015 | 913 | 0.100 |
Why?
|
Adrenergic alpha-2 Receptor Antagonists | 1 | 2012 | 18 | 0.100 |
Why?
|
Supraoptic Nucleus | 3 | 1999 | 28 | 0.100 |
Why?
|
Genes, Synthetic | 1 | 1992 | 88 | 0.100 |
Why?
|
Brain Waves | 1 | 2016 | 416 | 0.100 |
Why?
|
Administration, Sublingual | 1 | 2011 | 60 | 0.100 |
Why?
|
Health Care Surveys | 1 | 1999 | 2425 | 0.100 |
Why?
|
Normal Distribution | 2 | 2010 | 267 | 0.100 |
Why?
|
Body Weights and Measures | 1 | 2012 | 208 | 0.100 |
Why?
|
Appetite Depressants | 1 | 2012 | 108 | 0.100 |
Why?
|
Sensation | 3 | 2019 | 331 | 0.100 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2013 | 329 | 0.100 |
Why?
|
Receptors, Neurokinin-1 | 1 | 2012 | 133 | 0.100 |
Why?
|
Nerve Block | 1 | 1998 | 717 | 0.100 |
Why?
|
Genitalia, Female | 1 | 1992 | 146 | 0.090 |
Why?
|
Conscious Sedation | 1 | 2016 | 534 | 0.090 |
Why?
|
Adolescent Behavior | 1 | 2020 | 1185 | 0.090 |
Why?
|
Genetic Markers | 1 | 2017 | 2603 | 0.090 |
Why?
|
Visual Cortex | 1 | 2019 | 1081 | 0.090 |
Why?
|
Disease Progression | 3 | 2024 | 13642 | 0.090 |
Why?
|
Retina | 2 | 2019 | 2660 | 0.090 |
Why?
|
Saline Solution, Hypertonic | 3 | 1998 | 116 | 0.090 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2013 | 638 | 0.090 |
Why?
|
Homeostasis | 1 | 2022 | 3343 | 0.090 |
Why?
|
Forelimb | 1 | 2010 | 116 | 0.090 |
Why?
|
Spinal Cord Injuries | 1 | 2018 | 927 | 0.090 |
Why?
|
Bipolar Disorder | 3 | 2011 | 5130 | 0.090 |
Why?
|
Trans-Activators | 1 | 2000 | 2856 | 0.090 |
Why?
|
Time Factors | 6 | 2013 | 40149 | 0.090 |
Why?
|
Early Diagnosis | 1 | 2015 | 1186 | 0.090 |
Why?
|
Biomarkers, Pharmacological | 1 | 2011 | 161 | 0.090 |
Why?
|
Patient Compliance | 1 | 2000 | 2694 | 0.090 |
Why?
|
Organ Size | 1 | 2015 | 2262 | 0.090 |
Why?
|
Alzheimer Disease | 1 | 2011 | 8715 | 0.090 |
Why?
|
Caudate Nucleus | 1 | 2011 | 388 | 0.090 |
Why?
|
Models, Biological | 3 | 2014 | 9464 | 0.080 |
Why?
|
Phenotype | 3 | 2021 | 16722 | 0.080 |
Why?
|
Sex Factors | 2 | 2014 | 10619 | 0.080 |
Why?
|
Interleukin-6 | 1 | 2000 | 3226 | 0.080 |
Why?
|
Species Specificity | 2 | 2013 | 2413 | 0.080 |
Why?
|
Abdominal Pain | 1 | 2016 | 1069 | 0.080 |
Why?
|
Statistics as Topic | 2 | 2015 | 2350 | 0.080 |
Why?
|
Anticipation, Psychological | 1 | 2010 | 90 | 0.080 |
Why?
|
Aged | 12 | 2020 | 171344 | 0.080 |
Why?
|
Microelectrodes | 1 | 2010 | 305 | 0.080 |
Why?
|
Disabled Persons | 2 | 2017 | 1209 | 0.080 |
Why?
|
Self Report | 2 | 2020 | 3771 | 0.080 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2013 | 878 | 0.080 |
Why?
|
Psychotherapy | 2 | 2017 | 1648 | 0.080 |
Why?
|
Microscopy, Confocal | 1 | 2015 | 1969 | 0.080 |
Why?
|
Channelopathies | 1 | 2009 | 32 | 0.080 |
Why?
|
Circadian Rhythm | 3 | 2022 | 2590 | 0.080 |
Why?
|
Sleep | 4 | 2023 | 4814 | 0.080 |
Why?
|
Muscimol | 2 | 1999 | 70 | 0.080 |
Why?
|
Models, Genetic | 2 | 1996 | 3446 | 0.080 |
Why?
|
Radionuclide Imaging | 1 | 2012 | 1986 | 0.080 |
Why?
|
Linear Models | 3 | 2010 | 5873 | 0.080 |
Why?
|
Mice | 14 | 2023 | 81898 | 0.080 |
Why?
|
Antipsychotic Agents | 3 | 2013 | 3078 | 0.080 |
Why?
|
Echo-Planar Imaging | 1 | 2012 | 649 | 0.070 |
Why?
|
Weight Gain | 2 | 2012 | 2356 | 0.070 |
Why?
|
Reference Values | 2 | 2008 | 4914 | 0.070 |
Why?
|
Action Potentials | 2 | 2010 | 1835 | 0.070 |
Why?
|
Postoperative Complications | 2 | 2010 | 15831 | 0.070 |
Why?
|
Hypnotics and Sedatives | 1 | 2016 | 1193 | 0.070 |
Why?
|
Cerebellar Nuclei | 1 | 2008 | 54 | 0.070 |
Why?
|
Dreams | 1 | 2009 | 145 | 0.070 |
Why?
|
Recovery of Function | 1 | 2018 | 2978 | 0.070 |
Why?
|
Meta-Analysis as Topic | 1 | 2012 | 1365 | 0.070 |
Why?
|
Epilepsy | 1 | 2023 | 3317 | 0.070 |
Why?
|
Dipeptides | 1 | 2009 | 386 | 0.070 |
Why?
|
Estrogens | 1 | 2014 | 1528 | 0.070 |
Why?
|
Glucocorticoids | 1 | 1996 | 2158 | 0.070 |
Why?
|
Sympathetic Nervous System | 2 | 2022 | 520 | 0.070 |
Why?
|
Disease Management | 1 | 2017 | 2533 | 0.070 |
Why?
|
Dendritic Cells | 1 | 2018 | 2747 | 0.070 |
Why?
|
Military Personnel | 1 | 2016 | 1260 | 0.070 |
Why?
|
Perception | 1 | 2013 | 1204 | 0.070 |
Why?
|
Antibodies, Monoclonal | 1 | 2023 | 9244 | 0.070 |
Why?
|
Injections, Intraperitoneal | 2 | 2012 | 411 | 0.070 |
Why?
|
Socioeconomic Factors | 2 | 2018 | 7841 | 0.070 |
Why?
|
Limbic System | 1 | 2009 | 418 | 0.070 |
Why?
|
Severity of Illness Index | 2 | 2017 | 15912 | 0.060 |
Why?
|
Models, Economic | 1 | 2010 | 719 | 0.060 |
Why?
|
Research | 1 | 2014 | 1977 | 0.060 |
Why?
|
Physician-Patient Relations | 2 | 2014 | 3266 | 0.060 |
Why?
|
Inflammation | 3 | 2012 | 10863 | 0.060 |
Why?
|
Imipramine | 1 | 2005 | 96 | 0.060 |
Why?
|
Sensory Receptor Cells | 1 | 2010 | 509 | 0.060 |
Why?
|
Lower Extremity | 1 | 2013 | 1217 | 0.060 |
Why?
|
Postoperative Period | 1 | 2010 | 1824 | 0.060 |
Why?
|
Anti-Bacterial Agents | 1 | 2004 | 7475 | 0.060 |
Why?
|
Electric Stimulation | 2 | 2019 | 1736 | 0.060 |
Why?
|
Individuality | 1 | 2007 | 303 | 0.060 |
Why?
|
Prospective Studies | 4 | 2023 | 54872 | 0.060 |
Why?
|
DNA-Binding Proteins | 2 | 2000 | 9613 | 0.060 |
Why?
|
Cyclic AMP | 2 | 1999 | 1472 | 0.060 |
Why?
|
Transcription, Genetic | 1 | 1999 | 7612 | 0.060 |
Why?
|
Administration, Topical | 1 | 2007 | 702 | 0.060 |
Why?
|
Cognition | 2 | 2015 | 7057 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2017 | 3692 | 0.060 |
Why?
|
Injections | 1 | 2008 | 839 | 0.060 |
Why?
|
Eating | 2 | 2014 | 1539 | 0.060 |
Why?
|
Energy Intake | 1 | 2012 | 2142 | 0.060 |
Why?
|
Injections, Intramuscular | 2 | 2012 | 551 | 0.060 |
Why?
|
Receptors, GABA-A | 2 | 1986 | 624 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 2 | 2023 | 20710 | 0.060 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2011 | 1988 | 0.060 |
Why?
|
Child, Preschool | 2 | 2017 | 42577 | 0.050 |
Why?
|
Phosphorylation | 4 | 1999 | 8310 | 0.050 |
Why?
|
Drug Prescriptions | 1 | 2013 | 1663 | 0.050 |
Why?
|
Raynaud Disease | 1 | 2004 | 81 | 0.050 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2005 | 427 | 0.050 |
Why?
|
Wounds and Injuries | 1 | 2016 | 2513 | 0.050 |
Why?
|
Skin | 1 | 2017 | 4499 | 0.050 |
Why?
|
Macrophages | 1 | 2018 | 5784 | 0.050 |
Why?
|
Fourier Analysis | 1 | 2004 | 434 | 0.050 |
Why?
|
Catheter Ablation | 1 | 2016 | 2787 | 0.050 |
Why?
|
Receptor, Cannabinoid, CB1 | 1 | 2023 | 137 | 0.050 |
Why?
|
Fear | 2 | 2015 | 1496 | 0.050 |
Why?
|
Life Style | 1 | 2014 | 3926 | 0.050 |
Why?
|
Retrospective Studies | 5 | 2019 | 81657 | 0.050 |
Why?
|
Posterior Horn Cells | 1 | 2002 | 87 | 0.050 |
Why?
|
Suicide | 1 | 2013 | 1606 | 0.050 |
Why?
|
Brain Injuries | 1 | 2014 | 2053 | 0.050 |
Why?
|
Pyrogens | 2 | 1978 | 17 | 0.050 |
Why?
|
Data Interpretation, Statistical | 1 | 2011 | 2694 | 0.050 |
Why?
|
Adipose Tissue | 1 | 2013 | 3317 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-fos | 2 | 1994 | 582 | 0.050 |
Why?
|
Schizophrenia | 2 | 2013 | 6976 | 0.050 |
Why?
|
Age of Onset | 1 | 2008 | 3343 | 0.050 |
Why?
|
Neuropsychological Tests | 1 | 2014 | 7119 | 0.050 |
Why?
|
Excitatory Postsynaptic Potentials | 1 | 2002 | 369 | 0.050 |
Why?
|
Serotonin | 2 | 2014 | 1045 | 0.050 |
Why?
|
Baroreflex | 1 | 2022 | 154 | 0.050 |
Why?
|
Forecasting | 1 | 2010 | 2936 | 0.040 |
Why?
|
Solubility | 1 | 2002 | 1078 | 0.040 |
Why?
|
Freund's Adjuvant | 1 | 2000 | 144 | 0.040 |
Why?
|
Electronics, Medical | 1 | 2000 | 70 | 0.040 |
Why?
|
Ethics | 1 | 2000 | 93 | 0.040 |
Why?
|
Prosencephalon | 1 | 2002 | 305 | 0.040 |
Why?
|
Thumb | 1 | 2002 | 232 | 0.040 |
Why?
|
Spinal Nerves | 1 | 2000 | 92 | 0.040 |
Why?
|
Cells, Cultured | 4 | 1999 | 18986 | 0.040 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2010 | 6020 | 0.040 |
Why?
|
Toxicology | 1 | 2000 | 103 | 0.040 |
Why?
|
United States | 4 | 2020 | 72945 | 0.040 |
Why?
|
1-Methyl-3-isobutylxanthine | 1 | 1999 | 100 | 0.040 |
Why?
|
Rod Opsins | 1 | 2019 | 108 | 0.040 |
Why?
|
In Situ Hybridization | 2 | 1994 | 1892 | 0.040 |
Why?
|
Chloramphenicol O-Acetyltransferase | 1 | 1999 | 220 | 0.040 |
Why?
|
Phosphoserine | 1 | 1999 | 204 | 0.040 |
Why?
|
Drug Administration Routes | 1 | 1999 | 152 | 0.040 |
Why?
|
Injections, Intraventricular | 1 | 1999 | 227 | 0.040 |
Why?
|
Cyclic AMP Response Element Modulator | 1 | 1999 | 88 | 0.040 |
Why?
|
STAT1 Transcription Factor | 1 | 2000 | 340 | 0.040 |
Why?
|
Sacroiliac Joint | 1 | 1998 | 58 | 0.040 |
Why?
|
Aminooxyacetic Acid | 1 | 1998 | 7 | 0.040 |
Why?
|
Serologic Tests | 1 | 2000 | 382 | 0.040 |
Why?
|
Urinalysis | 1 | 2000 | 369 | 0.040 |
Why?
|
Hindlimb | 1 | 2000 | 513 | 0.040 |
Why?
|
Logistic Models | 2 | 2017 | 13276 | 0.040 |
Why?
|
Decision Making | 1 | 2012 | 3951 | 0.040 |
Why?
|
Iopamidol | 1 | 1998 | 188 | 0.040 |
Why?
|
Work Schedule Tolerance | 1 | 2022 | 553 | 0.040 |
Why?
|
Cost-Benefit Analysis | 1 | 2011 | 5536 | 0.040 |
Why?
|
Sciatica | 1 | 1998 | 97 | 0.040 |
Why?
|
GABA-A Receptor Agonists | 1 | 1998 | 86 | 0.040 |
Why?
|
Algorithms | 4 | 2011 | 14073 | 0.040 |
Why?
|
Skin Temperature | 2 | 1993 | 96 | 0.040 |
Why?
|
Education | 1 | 2020 | 531 | 0.040 |
Why?
|
Treatment Refusal | 1 | 2000 | 433 | 0.030 |
Why?
|
Patient Acceptance of Health Care | 1 | 2011 | 3230 | 0.030 |
Why?
|
Secondary Prevention | 1 | 2003 | 1469 | 0.030 |
Why?
|
Cryptosporidiosis | 1 | 1997 | 52 | 0.030 |
Why?
|
Models, Theoretical | 1 | 2009 | 3563 | 0.030 |
Why?
|
Hand Strength | 1 | 2020 | 466 | 0.030 |
Why?
|
Hair | 1 | 2000 | 508 | 0.030 |
Why?
|
Celiac Plexus | 1 | 1996 | 34 | 0.030 |
Why?
|
Sacrum | 1 | 1998 | 273 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 18076 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2000 | 1587 | 0.030 |
Why?
|
Radiography | 1 | 2008 | 6968 | 0.030 |
Why?
|
Vibration | 1 | 2019 | 334 | 0.030 |
Why?
|
src-Family Kinases | 1 | 1999 | 539 | 0.030 |
Why?
|
Occupational Therapy | 1 | 2017 | 140 | 0.030 |
Why?
|
Motor Neurons | 2 | 1998 | 869 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 2270 | 0.030 |
Why?
|
TRPV Cation Channels | 1 | 2018 | 244 | 0.030 |
Why?
|
Color | 1 | 2017 | 297 | 0.030 |
Why?
|
Water | 1 | 2002 | 1416 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2001 | 2846 | 0.030 |
Why?
|
Saliva | 1 | 2000 | 852 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2000 | 872 | 0.030 |
Why?
|
Biological Transport | 1 | 2020 | 2083 | 0.030 |
Why?
|
Organ Culture Techniques | 1 | 1998 | 789 | 0.030 |
Why?
|
Quality of Life | 2 | 2017 | 13476 | 0.030 |
Why?
|
Software | 1 | 2009 | 4464 | 0.030 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2008 | 2039 | 0.030 |
Why?
|
Rare Diseases | 1 | 2021 | 630 | 0.030 |
Why?
|
Disabled Children | 1 | 2018 | 250 | 0.030 |
Why?
|
Needles | 1 | 1998 | 461 | 0.030 |
Why?
|
Body Temperature Regulation | 1 | 1977 | 292 | 0.030 |
Why?
|
Risk Factors | 3 | 2019 | 74889 | 0.030 |
Why?
|
Clinical Laboratory Techniques | 1 | 2000 | 746 | 0.030 |
Why?
|
Body Temperature | 1 | 1978 | 780 | 0.030 |
Why?
|
Signal Transduction | 2 | 2013 | 23618 | 0.030 |
Why?
|
Anxiety Disorders | 1 | 2006 | 2743 | 0.030 |
Why?
|
Acetabulum | 1 | 1998 | 543 | 0.030 |
Why?
|
Methadone | 1 | 1997 | 317 | 0.030 |
Why?
|
Radiology, Interventional | 1 | 1998 | 483 | 0.030 |
Why?
|
Microdialysis | 1 | 2014 | 156 | 0.030 |
Why?
|
Retinal Ganglion Cells | 1 | 2019 | 810 | 0.030 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2022 | 2028 | 0.030 |
Why?
|
Osmotic Pressure | 1 | 1994 | 136 | 0.030 |
Why?
|
Hypothalamic Hormones | 1 | 2014 | 145 | 0.030 |
Why?
|
Pituitary Hormones | 1 | 2014 | 182 | 0.030 |
Why?
|
RNA, Messenger | 3 | 1999 | 12795 | 0.030 |
Why?
|
Depressive Disorder | 1 | 2006 | 3715 | 0.030 |
Why?
|
Glutamates | 1 | 2014 | 384 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 1994 | 287 | 0.030 |
Why?
|
Incidence | 2 | 2023 | 21527 | 0.030 |
Why?
|
Depressive Disorder, Major | 1 | 2011 | 4810 | 0.030 |
Why?
|
Vasopressins | 1 | 2014 | 358 | 0.030 |
Why?
|
Movement Disorders | 1 | 2016 | 462 | 0.030 |
Why?
|
Hypothalamus, Middle | 2 | 1997 | 15 | 0.030 |
Why?
|
Histamine | 1 | 2014 | 496 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2000 | 4853 | 0.030 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2010 | 1457 | 0.030 |
Why?
|
Blood Volume | 1 | 1994 | 544 | 0.020 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2022 | 1498 | 0.020 |
Why?
|
Melanins | 1 | 2014 | 291 | 0.020 |
Why?
|
Genes, jun | 1 | 1992 | 69 | 0.020 |
Why?
|
Femur | 1 | 1998 | 1318 | 0.020 |
Why?
|
Liver Function Tests | 1 | 2013 | 527 | 0.020 |
Why?
|
Appetite Regulation | 1 | 2012 | 84 | 0.020 |
Why?
|
Behavior Therapy | 1 | 2017 | 886 | 0.020 |
Why?
|
Norepinephrine | 1 | 2014 | 898 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2019 | 21162 | 0.020 |
Why?
|
Kinetics | 1 | 1999 | 6288 | 0.020 |
Why?
|
Prognosis | 1 | 2012 | 29959 | 0.020 |
Why?
|
Radiography, Interventional | 1 | 1998 | 1129 | 0.020 |
Why?
|
Mood Disorders | 1 | 2017 | 1127 | 0.020 |
Why?
|
Oligonucleotides | 1 | 1994 | 561 | 0.020 |
Why?
|
Peritoneal Neoplasms | 1 | 1997 | 706 | 0.020 |
Why?
|
Heart Rate | 1 | 2022 | 4207 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 1996 | 4168 | 0.020 |
Why?
|
Oxytocin | 1 | 2014 | 403 | 0.020 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1994 | 792 | 0.020 |
Why?
|
Up-Regulation | 1 | 1999 | 4143 | 0.020 |
Why?
|
Estradiol | 1 | 1997 | 1947 | 0.020 |
Why?
|
Tissue Distribution | 1 | 1994 | 2275 | 0.020 |
Why?
|
Pancreatitis | 1 | 1996 | 1087 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2015 | 2921 | 0.020 |
Why?
|
Fever | 1 | 1977 | 1607 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2023 | 3927 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 1999 | 6507 | 0.020 |
Why?
|
Hypertension | 1 | 2009 | 8616 | 0.020 |
Why?
|
Drug Synergism | 1 | 2013 | 1757 | 0.020 |
Why?
|
Euphoria | 1 | 2008 | 64 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2011 | 949 | 0.020 |
Why?
|
Delayed-Action Preparations | 1 | 2012 | 966 | 0.020 |
Why?
|
Axons | 1 | 1996 | 1675 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2012 | 1887 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2015 | 1828 | 0.020 |
Why?
|
Repressor Proteins | 1 | 1999 | 2979 | 0.020 |
Why?
|
Arteries | 1 | 2013 | 1123 | 0.020 |
Why?
|
Random Allocation | 1 | 2012 | 2394 | 0.020 |
Why?
|
Protein Binding | 1 | 2000 | 9326 | 0.020 |
Why?
|
Drug Interactions | 1 | 2012 | 1419 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2017 | 59548 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2018 | 22351 | 0.020 |
Why?
|
Boston | 1 | 2019 | 9346 | 0.020 |
Why?
|
Escherichia coli | 1 | 1999 | 4211 | 0.020 |
Why?
|
Stomach Neoplasms | 1 | 1997 | 1480 | 0.020 |
Why?
|
4-Aminobutyrate Transaminase | 1 | 1986 | 13 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2000 | 11062 | 0.020 |
Why?
|
Blood Pressure | 1 | 2022 | 8533 | 0.020 |
Why?
|
Glutamate Dehydrogenase | 1 | 1986 | 50 | 0.020 |
Why?
|
Computer Simulation | 2 | 2010 | 6258 | 0.020 |
Why?
|
Aldehyde Oxidoreductases | 1 | 1986 | 88 | 0.020 |
Why?
|
Flunitrazepam | 1 | 1985 | 20 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2009 | 993 | 0.020 |
Why?
|
Base Sequence | 2 | 1994 | 12415 | 0.020 |
Why?
|
Peroxides | 1 | 2005 | 76 | 0.020 |
Why?
|
Synaptic Membranes | 1 | 1985 | 88 | 0.020 |
Why?
|
Enzyme Induction | 1 | 1986 | 455 | 0.020 |
Why?
|
Contrast Media | 1 | 1998 | 5329 | 0.020 |
Why?
|
Suprachiasmatic Nucleus | 1 | 1986 | 141 | 0.020 |
Why?
|
Carbamazepine | 1 | 1986 | 224 | 0.020 |
Why?
|
Functional Laterality | 2 | 2005 | 2244 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2017 | 39312 | 0.010 |
Why?
|
Succinate-Semialdehyde Dehydrogenase | 1 | 1986 | 96 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2000 | 14473 | 0.010 |
Why?
|
Behavior, Animal | 1 | 2012 | 1865 | 0.010 |
Why?
|
Attention | 1 | 2014 | 2413 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2014 | 2887 | 0.010 |
Why?
|
Leptin | 1 | 2012 | 1596 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 1985 | 2078 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 1994 | 17609 | 0.010 |
Why?
|
Acetylcholine | 1 | 1986 | 628 | 0.010 |
Why?
|
Zollinger-Ellison Syndrome | 1 | 1983 | 13 | 0.010 |
Why?
|
Urea | 1 | 2005 | 449 | 0.010 |
Why?
|
Valproic Acid | 1 | 1986 | 444 | 0.010 |
Why?
|
Pyloric Antrum | 1 | 1983 | 66 | 0.010 |
Why?
|
Stomach Ulcer | 1 | 1983 | 118 | 0.010 |
Why?
|
Lithium | 1 | 1986 | 599 | 0.010 |
Why?
|
Gene Expression | 1 | 1995 | 7585 | 0.010 |
Why?
|
Lipids | 1 | 2013 | 3322 | 0.010 |
Why?
|
Clozapine | 1 | 2006 | 509 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2019 | 14762 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 1999 | 7430 | 0.010 |
Why?
|
Palliative Care | 1 | 1997 | 3640 | 0.010 |
Why?
|
Rabbits | 2 | 1978 | 4752 | 0.010 |
Why?
|
Risk Assessment | 2 | 2015 | 24299 | 0.010 |
Why?
|
Bayes Theorem | 1 | 2009 | 2353 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2015 | 14653 | 0.010 |
Why?
|
Feeding Behavior | 1 | 2012 | 3208 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2013 | 3989 | 0.010 |
Why?
|
Quinones | 1 | 1999 | 79 | 0.010 |
Why?
|
Rifabutin | 1 | 1999 | 53 | 0.010 |
Why?
|
Benzoquinones | 1 | 1999 | 198 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2005 | 2721 | 0.010 |
Why?
|
Psychotic Disorders | 1 | 2013 | 3275 | 0.010 |
Why?
|
Gastrectomy | 1 | 1983 | 693 | 0.010 |
Why?
|
Fenclonine | 1 | 1977 | 16 | 0.010 |
Why?
|
Genetic Variation | 1 | 2013 | 6613 | 0.010 |
Why?
|
Lactams, Macrocyclic | 1 | 1999 | 319 | 0.010 |
Why?
|
Prostaglandins E | 1 | 1977 | 166 | 0.010 |
Why?
|
Spinothalamic Tracts | 1 | 1996 | 8 | 0.010 |
Why?
|
Promoter Regions, Genetic | 2 | 1999 | 5795 | 0.010 |
Why?
|
Hydromorphone | 1 | 1997 | 70 | 0.010 |
Why?
|
Papio | 1 | 1978 | 672 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 13644 | 0.010 |
Why?
|
Body Mass Index | 1 | 2013 | 13050 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2013 | 10384 | 0.010 |
Why?
|
Retreatment | 1 | 1997 | 598 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2006 | 2903 | 0.010 |
Why?
|
Ovariectomy | 1 | 1997 | 612 | 0.010 |
Why?
|
Thermoreceptors | 1 | 1993 | 27 | 0.010 |
Why?
|
Animals, Newborn | 1 | 1999 | 2677 | 0.010 |
Why?
|
Infant | 1 | 2015 | 36459 | 0.010 |
Why?
|
Enhancer Elements, Genetic | 1 | 1999 | 1366 | 0.010 |
Why?
|
Cattle | 1 | 1978 | 3815 | 0.010 |
Why?
|
Cell Count | 1 | 1996 | 1826 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2008 | 15425 | 0.010 |
Why?
|
Astrocytes | 1 | 1999 | 1351 | 0.010 |
Why?
|
Transfection | 1 | 1999 | 5755 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 1993 | 1697 | 0.010 |
Why?
|
Pregnancy | 1 | 1992 | 30236 | 0.010 |
Why?
|
Leukocytes | 1 | 1978 | 2034 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 1999 | 3723 | 0.000 |
Why?
|
Swine | 1 | 1978 | 5985 | 0.000 |
Why?
|
Recurrence | 1 | 1983 | 8507 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1983 | 12985 | 0.000 |
Why?
|